Skip to Main Content
Products
Oncology
Prenatal
Technology
Technology
Publications
Careers
Working with us
Open Positions
Company
Mission, Vision, Values
Leadership & Board
Company Milestones
News & Media
Press Releases
Events
Media Coverage
Social Media
Investors
Contact
News & Media
All Resources
All Categories
Media Coverage
Press Releases
General Information
All Years
2025
2024
2023
2022
2021
2020
2019
Filter by Category
Media Coverage
Press Releases
General Information
Filter by Year
2025
2024
2023
2022
2021
2020
2019
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Media Coverage
Media Coverage
March 19, 2024
2024
2024
BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!
Learn More
Media Coverage
March 19, 2024
2024
2024
BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!
Learn More
Press Releases
Press Releases
February 21, 2024
2024
2024
BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER
Learn More
Press Releases
February 21, 2024
2024
2024
BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER
Learn More
Press Releases
Press Releases
January 2, 2024
2024
2024
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Learn More
Press Releases
January 2, 2024
2024
2024
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Learn More
Press Releases
Press Releases
December 12, 2023
2023
2023
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
Learn More
Press Releases
December 12, 2023
2023
2023
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
Learn More
Media Coverage
Media Coverage
December 7, 2023
2023
2023
UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.
Learn More
Media Coverage
December 7, 2023
2023
2023
UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.
Learn More
Media Coverage
Media Coverage
December 5, 2023
2023
2023
BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights
Learn More
Media Coverage
December 5, 2023
2023
2023
BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights
Learn More
Press Releases
Press Releases
October 30, 2023
2023
2023
BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population
Learn More
Press Releases
October 30, 2023
2023
2023
BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population
Learn More
Press Releases
Press Releases
August 11, 2023
2023
2023
BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy
Learn More
Press Releases
August 11, 2023
2023
2023
BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy
Learn More
1
Social Posts
Follow us
LinkedIn
X
Social Posts